| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |